Late effects of mustard gas agents on immune system in 40 patients

D. Attaran, M. Mahmoodi, M. Balali, M. Hefazi (Mashad, Mashdad, Iran)

Source: Annual Congress 2004 - Immunology in pulmonary diseases
Session: Immunology in pulmonary diseases
Session type: Thematic Poster Session
Number: 2236
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. Attaran, M. Mahmoodi, M. Balali, M. Hefazi (Mashad, Mashdad, Iran). Late effects of mustard gas agents on immune system in 40 patients. Eur Respir J 2004; 24: Suppl. 48, 2236

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The effect of oral corticosteroid on spirometeric parameters in COPD patients induced by mustard gas
Source: Eur Respir J 2006; 28: Suppl. 50, 216s
Year: 2006

Chronic respiratory effects of war-related sulfur mustard gas inhalation
Source: Annual Congress 2007 - Experimental and observational studies with environmental agents
Year: 2007


The harmful effects of nitrogen mustard on lung and the contribution of proanthocyanidin to decrease this effect
Source: Annual Congress 2008 - Border patrol: the alveolar barrier in lung injury
Year: 2008


Mechanisms of systemic side effects of inhaled steroids
Source: Eur Respir J 2004; 24: Suppl. 48, 347s
Year: 2004

An influence of small doses of corticosteroids on immune defense in active pulmonary tuberculosis in humans
Source: Annual Congress 2009 - Clinical immunology of tuberculosis
Year: 2009

The effect of oral zinc sulphate on immune system of patients with pulmonary tuberculosis
Source: Annual Congress 2008 - Miscellaneous respiratory infections
Year: 2008


The potentially beneficial central nervous system activity profile of ivacaftor and its metabolites
Source: ERJ Open Res, 4 (1) 00127-2017; 10.1183/23120541.00127-2017
Year: 2018



Late Breaking Abstract - The outcome of COVID-19 in interstitial lung disease patients treated with anti-inflammatory drugs and antiviral drugs
Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases
Year: 2021


Effect of nicotine on the system of cell-mediated immunity in COPD
Source: International Congress 2019 – COPD, asthma and rhinitis: from cellular mechanisms to patients’ clinical responses
Year: 2019

Diagnostic and therapeutic value of short-term corticosteroid therapy in exacerbation of mustard gas induced COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 298s
Year: 2005

Hepatotoxic reactions in rats after administration of component schemes of reserve Anti-TB drugs with different safety profile
Source: International Congress 2019 – Tuberculosis: from basic science to patient care
Year: 2019

Clinical findings in mustard gas induced lung injury
Source: Eur Respir J 2004; 24: Suppl. 48, 364s
Year: 2004

Free radical status and antioxidant defense in children with asthma treated by inhaled corticosteroids combined with prolonged β2-agonist
Source: Eur Respir J 2006; 28: Suppl. 50, 483s
Year: 2006

The influence of endobronchial laser irradiation on gas transport and immune cells functions
Source: Annual Congress 2008 - Regulatory mechanisms of cell activation, renewal and recruitment
Year: 2008

The integration of immune system changes and febrile reaction induced by pyrogenal injection in advanced COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 253s
Year: 2002

How to use new immunosuppressive drugs in lung transplantation
Source: Annual Congress 2006 - MP5 – How to use new immunosuppressive drugs in lung transplantation
Year: 2006

Role of altered immune response in CF and implication for antiinflammatory therapies
Source: Research Seminar 2012 - Pulmonary inflammation in paediatric respiratory disease
Year: 2012


A new method to estimate the long-term effect of immunosuppressants and vasodilator therapies on lung function outcomes in systemic sclerosis patients
Source: Virtual Congress 2020 – Predictive markers of progression in connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis
Year: 2020


Improving the innate immune response in respiratory infections: the use of repurposed drugs
Source: Virtual Congress 2020 – Antibiotic resistance: the way forward
Year: 2020